PREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trial

J Heart Lung Transplant. 2020 Aug;39(8):838-840. doi: 10.1016/j.healun.2020.05.003. Epub 2020 May 16.

Authors

Affiliations

¹ Montefiore Einstein Center for Heart and Vascular Care, Bronx, New York.
² Department of Medicine, Duke University, Durham, North Carolina.
³ Columbia University Irving Medical Center, New York, New York.
⁴ Mayo Clinic, Rochester, Minnesota.
⁵ Christ Hospital, Cincinnati, Ohio.
⁶ Seton Medical Center, Austin, Texas.
⁷ Palmetto Health Richland, Columbia, South Carolina.
⁸ Abbott, Chicago, Illinois.
⁹ Sharp Memorial Hospital, San Diego, California.

PMID: 32571737
DOI: 10.1016/j.healun.2020.05.003

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Clinical Trials as Topic
Conservative Treatment / methods*
Heart Failure / surgery*
Heart-Assist Devices / adverse effects*
Hemorrhage / etiology
Hemorrhage / prevention & control*
Humans

Grants and funding